Moschou Georgia* and Topham H. Caroline
Department of Biotechnology, University of Salford, UK
*Corresponding Author: Moschou Georgia, Department of Biotechnology, University of Salford, UK.
Received: April 13, 2020; Published: June 17, 2020
Medulloblastoma (MB) constitutes the commonest malignant childhood brain cancer, and it is the leading cause of death in infants under 1 year. Treatment approaches, such as surgery, radiation, and chemotherapy, have significantly enhanced in patients’ clinical outcome with approximately more than 60% of 5-year survival. Nevertheless, the majority of cancer patients deal with long-term side effects. So, it is important to develop novel therapeutics with lower toxicity and increased efficacy. The present project was conducted to examine if the anti-allergy drugs can inhibit the cancer growth. More specifically, eight anti-allergy compounds, designed by the chemists at University of Central Lancashire (UCLAN), were evaluated for their anti-cancer activity against medulloblastoma. The effect of each testing drug was tested with the use of MTT assay after three days of incubation on medulloblastoma ONS76 cell line. From the extraction of the results of these anti-allergy compounds, it was found that only three of them (CL1-45-1, CL1-56-1, CL1-57-1) were more active, as they significantly inhibited the cancer growth. But, the CL1-42-1 compound displayed the greatest anti-cancer activity against the medulloblastoma ONS76 cells with IC50 = >10 μΜ (IC50 = 0 μΜ). This leads to the conclusion for further investigation of the anti-allergy compounds in order to consider them as potential anti-cancer agents.
Keywords: Anti-Allergy Drugs; Cancer; Anti-Cancer Agents, Drug-repurposing
Citation: Moschou Georgia and Topham H Caroline. “Drug Re-Purposing - Can Anti-Allergy Drugs also be Used to Treat Cancer ?". Acta Scientific Microbiology 3.7 (2020): 31-45.
Copyright: © 2020 Moschou Georgia and Topham H Caroline. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.